This could be attributed to the fact that PIK3CA and RUNX1 mutations are commonly observed in luminal-type breast cancer; in the intrinsic subtype, CDH1-altered ILC exhibited a higher proportion of luminal-type cases. This evidence concerns the gene PIK3CA and breast cancer.